235. Hypoparathyroidism
67 clinical trials,   112 drugs   (DrugBank: 24 drugs),   4 drug target genes,   5 drug target pathways

Searched query = "Hypoparathyroidism", "Accessory thyroid hypergasia disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04009291
(ClinicalTrials.gov)
August 27, 201920/6/2019A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With HypoparathyroidismPaTH Forward: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial With an Open-Label Extension, Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Subcutaneously Daily in Adults With HypoparathyroidismHypoparathyroidism;Endocrine System Diseases;Parathyroid DiseasesCombination Product: TransCon PTH;Combination Product: Placebo for TransCon PTHAscendis Pharma A/SNULLActive, not recruiting18 YearsN/AAll40Phase 2United States;Canada;Denmark;Germany;Italy;Norway;United Kingdom